Kanka Gel
NDC 10157-2106
Product Information
Kanka (benzocaine and zinc chloride) is a OTC MONOGRAPH DRUG-approved product labeled by Blistex Inc. This medication is typically used as a allergens [cs]. It is supplied as a gel for oral administration. This product entry covers the primary NDC 10157-2106 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 10157-2106?
What are the uses of this product?
What are Active Ingredients of this product?
- BENZOCAINE 20 mg/100g - A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.
- ZINC CHLORIDE .1 g/100g - RN given refers to parent cpd
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BENZOCAINE (UNII: U3RSY48JW5)
- BENZOCAINE (UNII: U3RSY48JW5) (Active Moiety)
- ZINC CHLORIDE (UNII: 86Q357L16B)
- ZINC CATION (UNII: 13S1S8SF37) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
- GLYCERIN (UNII: PDC6A3C0OX)
- SUCRALOSE (UNII: 96K6UQ3ZD4)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1249105 - benzocaine 20 % / zinc chloride 0.1 % Oral Gel
- RxCUI: 1249105 - benzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral Gel
Which are the Pharmacologic Classes of this product?
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
* Please review the full disclaimer at the bottom of this page.